Login / Signup

Real-World Healthcare Resource Utilization (HRU) and Costs of Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Receiving Eculizumab in a US Population.

Wendy Y ChengSujata P SardaNikita Mody-PatelSangeeta KrishnanMihran YenikomshianMalena MahendranDominique LejeuneLouise H YuMei Sheng Duh
Published in: Advances in therapy (2021)
The economic burden of patients with PNH treated with eculizumab is greater among those dependent on blood transfusions.
Keyphrases
  • healthcare
  • atrial fibrillation
  • blood pressure
  • obstructive sleep apnea
  • sleep quality
  • newly diagnosed
  • depressive symptoms